53 related articles for article (PubMed ID: 6883768)
1. [Radioimmunoassay of plasma neurotensin and clinical application].
Matsumura M; Ono M; Mori H; Saito S
Horumon To Rinsho; 1983 Jun; 31(6):531-4. PubMed ID: 6883768
[No Abstract] [Full Text] [Related]
2. A radioimmunoassay for neurotensin.
Kronheim S; Sheppard MC; Miller J
Clin Endocrinol (Oxf); 1981 Feb; 14(2):159-64. PubMed ID: 7261413
[TBL] [Abstract][Full Text] [Related]
3. A radioimmunoassay for neurotensin in human plasma.
Shulkes A; Chick P; Wong H; Walsh JH
Clin Chim Acta; 1982 Oct; 125(1):49-58. PubMed ID: 7139948
[TBL] [Abstract][Full Text] [Related]
4. Concentration of neurotensin in human plasma after glucose, meals and lipids.
Flaten O; Hanssen LE
Acta Physiol Scand; 1982 Feb; 114(2):311-3. PubMed ID: 7136762
[No Abstract] [Full Text] [Related]
5. The effect of ingestion of amino acids, glucose and fat on circulating neurotensin-like immunoreactivity (NTLI) in man.
Rosell S; Rökaeus A
Acta Physiol Scand; 1979 Nov; 107(3):263-67. PubMed ID: 539456
[TBL] [Abstract][Full Text] [Related]
6. [Plasma neurotensin assay and the clinical significance].
Ishizuka J; Toyota T
Nihon Rinsho; 1990 Feb; 48 Suppl():36-9. PubMed ID: 2355556
[No Abstract] [Full Text] [Related]
7. A radioimmunoassay for neurotensin in human plasma.
Blackburn AM; Bloom SR
J Endocrinol; 1979 Nov; 83(2):175-81. PubMed ID: 574894
[TBL] [Abstract][Full Text] [Related]
8. [The radioimmunological analysis of neuropeptides in cancer patients].
Ishkhanova MA; Mitriaeva NA; Vusik IM; Mikhanovskiĭ AA; Voloshin VS; Starikov VI
Vopr Onkol; 1992; 38(11):1375-6. PubMed ID: 1343175
[No Abstract] [Full Text] [Related]
9. Plasma levels of neurotensin in gastroplasty for morbid obesity.
Miskowiak J; Pedersen JH; Andersen B; Stadil F
Regul Pept; 1984 Nov; 9(4):263-9. PubMed ID: 6522643
[TBL] [Abstract][Full Text] [Related]
10. In vitro degradation of neurotensin in human plasma.
Lee YC; Uttenthal LO; Smith HA; Bloom SR
Peptides; 1986; 7(3):383-7. PubMed ID: 3774585
[TBL] [Abstract][Full Text] [Related]
11. Characterization of fat-induced neurotensin-like immunoreactivity in plasma using column liquid chromatography and radioimmunoassay.
Draviam EJ; Greeley GH; Lluis F; Uchida T; Trowbridge J; Thompson JC
J Chromatogr; 1987 Feb; 414(1):180-6. PubMed ID: 3571382
[No Abstract] [Full Text] [Related]
12. Plasma cholecystokinin and neurotensin after an ordinary meal in humans. A prolonged time study.
Gullo L; Pezzilli R; Tomassetti P; de Giorgio R
Gastroenterol Clin Biol; 1998 Jan; 22(1):25-8. PubMed ID: 9762162
[TBL] [Abstract][Full Text] [Related]
13. Relation between lower esophageal sphincter (LES) pressure and the plasma concentration of neurotensin during intravenous infusion of neurotensin(1-13) and (Gln4)neurotensin(1-13) in man.
Theodorsson-Norheim E; Thor K; Rosell S
Acta Physiol Scand Suppl; 1983; 515():29-35. PubMed ID: 6578671
[TBL] [Abstract][Full Text] [Related]
14. [Neurotensin].
Satoh K; Shimosegawa T
Nihon Rinsho; 2010 Jul; 68 Suppl 7():269-72. PubMed ID: 20960781
[No Abstract] [Full Text] [Related]
15. Plasma radioimmunoassayable neurotensin responses to the administration of various nutrients.
Ito S; Matsubara Y; Sihibata A
Tohoku J Exp Med; 1982 Jan; 136(1):109-10. PubMed ID: 7071824
[TBL] [Abstract][Full Text] [Related]
16. Increased plasma neurotensin concentrations in patients with Parkinson's disease.
Schimpff RM; Avard C; Fénelon G; Lhiaubet AM; Tennezé L; Vidailhet M; Rostène W
J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):784-6. PubMed ID: 11385014
[TBL] [Abstract][Full Text] [Related]
17. Plasma neurotensin: lack of a differentiation and tumor marker in children with neuroblastoma.
Becker K; Berthold F
Pediatr Hematol Oncol; 1992; 9(3):269-72. PubMed ID: 1525006
[TBL] [Abstract][Full Text] [Related]
18. Enhanced neurotensin-like immunoreactivity release in total gastrectomized patients after 50 g OGTT.
Ito S; Matsubara Y; Iwasaki Y; Momotsu T; Shibata A; Muto T
Horm Metab Res; 1980 Oct; 12(10):551-2. PubMed ID: 7439880
[TBL] [Abstract][Full Text] [Related]
19. [Effect of neuropeptide Y and neurotensin on diurnal rhythm of blood pressure and target organ damage for essential hypertension].
Guo XW; Wang XL; Gao ZL
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Nov; 33(11):1006-9. PubMed ID: 16563248
[TBL] [Abstract][Full Text] [Related]
20. [Immunoreactive neurotensin in children with gastrointestinal diseases].
Teufel M; Niessen KH
Monatsschr Kinderheilkd; 1986 Feb; 134(2):96-101. PubMed ID: 3702882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
